Verano Holdings (VRNO) Other Non Operating Income (2022 - 2026)
Verano Holdings' (VRNO) quarterly Other Non Operating Income came in at -$1.2 million in Q1 2026, down 125.79% year-on-year from $4.7 million in Q1 2025, and up 91.86% on a QoQ basis from -$15.0 million in Q4 2025.
Verano Holdings (VRNO) Other Non Operating Income (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Other Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 125.79% year-over-year to -$1.2 million in Q1 2026; TTM through Mar 2026 was -$15.0 million, a 372.34% decrease from a year earlier, with the FY2025 full-year figure at -$10.3 million, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1.2 million, up from -$15.0 million in the prior quarter.
- Over the last five years, Other Non Operating Income for VRNO reached as high as $31.6 million in Q4 2022 and fell as low as -$15.0 million in Q4 2025.
- Historically, Other Non Operating Income has averaged $1.7 million across 5 years, with a median of -$484000.0 in 2024.
- Across the five-year window, Other Non Operating Income soared 460.5% in 2023 and plunged 715.83% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $31.6 million in 2022, then plunged by 108.03% to -$2.5 million in 2023, then jumped by 195.91% to $2.4 million in 2024, then plunged by 715.83% to -$15.0 million in 2025, then jumped by 91.86% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$1.2 million in Q1 2026, -$15.0 million in Q4 2025, and $1.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -15.01 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | -484,000.00 |
| Jun 30, 2024 | -1.20 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | -1.41 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 31.64 Mn |
| Sep 30, 2022 | -595,000.00 |